Related Experiment Video
Updated: Aug 25, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Methicillin-resistant Staphylococcus aureus: need for constant surveillance,stringent control and vigorous treatment
Dalip K Kakru1, Shiekh Assadullah, Manzoor A Thoker
1Dept. of Clinical Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir.
Abstract:
Staphylococcus aureus has shown a disconcerting propensity to develop resistance to antimicrobial agents and an increasing proportion of these have become resistant to methicillin as well. Regular surveillance should be carried out in every hospital and stringent infection control measures and vigorous treatment should be employed to prevent the nosocomial spread of MRSA. A total of 1056 MRSA were isolated from various specimens received in bacteriology division of SKIMS Srinagar out of which 46.32% were from inpatients and 31.87% from outpatients. None of these strains showed resistance to vancomycin and a good proportion were sensitive to amikacin (80.75%) gentamicin (69%) or ciprofloxacin (63.25%).
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern in hospitals. Surveillance and infection control are vital, as this study found MRSA strains remained sensitive to vancomycin, amikacin, gentamicin, and ciprofloxacin.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Hospital Epidemiology
Background:
- Staphylococcus aureus exhibits increasing antimicrobial resistance, particularly methicillin resistance.
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat for nosocomial infections.
- Effective surveillance and infection control are crucial to mitigate MRSA spread.
Purpose of the Study:
- To investigate the prevalence and antimicrobial susceptibility patterns of MRSA isolates.
- To assess the resistance of MRSA to commonly used antibiotics in a hospital setting.
Main Methods:
- Retrospective analysis of 1056 MRSA isolates from clinical specimens.
- Antimicrobial susceptibility testing was performed on isolated MRSA strains.
Main Results:
- MRSA was isolated from both inpatient (46.32%) and outpatient (31.87%) settings.
- No vancomycin resistance was observed in any MRSA isolates.
- High sensitivity rates were noted for amikacin (80.75%), gentamicin (69%), and ciprofloxacin (63.25%).
Conclusions:
- MRSA remains a significant pathogen, necessitating ongoing surveillance and stringent infection control.
- Vancomycin is a reliable treatment option against MRSA in this region.
- Amikacin, gentamicin, and ciprofloxacin show considerable efficacy against prevalent MRSA strains.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Methods for Controlling Microbial Growth
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Endocarditis III: Medical Management